tiprankstipranks
C4 Therapeutics (CCCC)
NASDAQ:CCCC
US Market

C4 Therapeutics (CCCC) Balance Sheet

409 Followers

C4 Therapeutics Balance Sheet

C4 Therapeutics's total assets for Q4 2023 were $376.45M, an increase of 13.04% from the previous quarter. CCCC total liabilities were $130.34M for the fiscal quarter, a 11.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 376.45M$ 430.84M$ 506.76M$ 400.14M$ 118.26M
Total Liabilities
$ 130.34M$ 141.61M$ 117.16M$ 119.35M$ 230.22M
Total Equity Gross Minority
$ 246.10M$ 289.22M$ 389.61M$ 280.79M$ -111.96M
Total Capitalization
$ 311.87M$ 605.79M$ 775.73M$ 290.84M$ -111.96M
Preferred Stock Equity
----$ 111.00M
Capital Lease Obligations
---$ 12.87M$ 13.75M
Currency in USD

C4 Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis